Sign In
14 May 2019 12:00
14 May 2019
Microsaic Systems plcĀ
("Microsaic", "Microsaic Systems" or the "Company")
Result of AGMĀ
Ā
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that all resolutions were duly passed at its Annual General Meeting today.
Ā
Enquiries: Ā | Ā |
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD | +44 (0) 1483 751 577 |
Ā N+1 Singer (Nominated Adviser & Broker) Shaun Dobson (Corporate Finance) Tom Salvesen (Corporate Broking) Ā | Ā +44 (0)20 7496 3000 |
IFC Advisory Ltd (Financial PR) Graham Herring Heather Armstrong Florence Chandler | +44 (0)20 3934 6630 |
Ā
About Microsaic Systems
Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.
Ā
Microsaic's core product, the 4500 MiDĀ®, is a robust and compact MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.
Ā
Ā
Ā
Follow the stocks
